• Precision Medicine Initiative S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2017, NIH funding Public Law 114-113, Consolidated Appropriations Act, FY2016, NIH funding National Cancer Moonshot program Monitor the following: Public Law 111-148, Patient Protection and Affordable Care Act, Monitor Medicare Reimbursement; Comparative Effectiveness Research; Geographic Variation; and issues related to Academic Health Centers H.R.6, 21st Century Cures Act, Advancing translational research H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act, generally
• Monitor the following: Public Law 111-148, Patient Protection and Affordable Care Act (PPACA), Medicare Reimbursement; and Comparative Effectiveness Research. Implementation of PPA GME issues
• H.R.6132, National Trauma Care System Act Monitor the following: Public Law 111-148, Patient Protection and Affordable Care Act, Medicare Reimbursement; Comparative Effectiveness Research; and Federal Medical Assistance Payments (FMAP) issues. Federal Medical Assistance Payments (FMAP) legislation and tax extenders. CMS reimbursement issues.
• Monitor the following: Physician payment issues Sustainable Growth Rate (SGR) Formula Non-profit hospital regulations and oversight Comparative effectiveness research Reimbursement issues
• No lobbying activity.

Duration: November 1, 2007 to December 31, 2016

General Issues: Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy, Veterans

Spending: about $1,630,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: House of Representatives, U.S. Senate, Office of the Vice President of the United States, Executive Office of the President (EOP), U.S. Senate,, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Y Y Food and Drug Administration, Department of Health and Human Services Food and Drug Administration, Y Y